<DOC>
	<DOC>NCT01893437</DOC>
	<brief_summary>This single-center, randomized, double-blind, placebo-controlled, single dose study will investigate the safety, pharmacokinetics, pharmacodynamics of RO6799477 in healthy volunteers.</brief_summary>
	<brief_title>A Study of RO6799477 in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Male healthy volunteers, aged 1845 years, inclusive Male volunteers with female partner of childbearing potential must agree to use an effective form of birth control during the study and for 3 months after discontinuation of treatment. Body Mass index (BMI) of 1830 kg/m2, inclusive Infection with human immunodeficiency virus antibody (HIV 1 and 2), Hepatitis B, hepatitis C Positive testing for drugs of abuse Any history of alcohol and/or drug of abuse addiction</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>